stoxline Quote Chart Rank Option Currency Glossary
  
Endo International plc (ENDP)
0.3744  0.007 (1.99%)    08-15 16:00
Open: 0.39
High: 0.3976
Volume: 20,613,041
  
Pre. Close: 0.3671
Low: 0.37
Market Cap: 0(M)
Technical analysis
2022-11-18 4:20:14 PM
Short term     
Mid term     
Targets 6-month :  0.34 1-year :  0.35
Resists First :  0.29 Second :  0.3
Pivot price 0.29
Supports First :  0.28 Second :  0.23
MAs MA(5) :  0.29 MA(20) :  0.29
MA(100) :  0.31 MA(250) :  1.62
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  47.4 D(3) :  47.4
RSI RSI(14): 69.7
52-week High :  6.03 Low :  0.08
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ENDP ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.31 - 0.31 0.31 - 0.31
Low: 0.28 - 0.28 0.28 - 0.28
Close: 0.29 - 0.29 0.29 - 0.3
Company Description

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Headline News

Fri, 19 Aug 2022
Endo: End Game And What Burned Investors Can Learn (NASDAQ:ENDP) - Seeking Alpha

Tue, 16 Aug 2022
Endo Creditors Eye Plan for Drugmaker's Sale Through Bankruptcy - Bloomberg

Tue, 09 Aug 2022
Endo International (ENDP) Stock Plunges Amid Bankruptcy Warning - InvestorPlace

Fri, 01 Jul 2022
Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants ... - PR Newswire

Thu, 30 Jun 2022
Why Endo (ENDP) Stock Wilted After its Surge on Tuesday? - Yahoo Finance

Wed, 18 May 2022
Why Shares of Endo International Plummeted 69% on Wednesday - The Motley Fool

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers—Specialty & Generic
Shares Out 234 (M)
Shares Float 199 (M)
Held by Insiders 0.7 (%)
Held by Institutions 83.6 (%)
Shares Short 41,450 (K)
Shares Short P.Month 32,790 (K)
Stock Financials
EPS 0.78
EPS Est Next Qtrly 0.7
EPS Est This Year 3.51
EPS Est Next Year 3
Book Value (p.s.) -2.81
Profit Margin -24.9 %
Operating Margin 24.7 %
Return on Assets (ttm) 5.1 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -9.2 %
Gross Profit (p.s.) 7.61
Sales Per Share 12.53
EBITDA (p.s.) 3.05
Qtrly Earnings Growth 0 %
Operating Cash Flow 369 (M)
Levered Free Cash Flow 639 (M)
Stock Valuations
PE Ratio 0.37
PEG Ratio -0.1
Price to Book value -0.11
Price to Sales 0.02
Price to Cash Flow 0.18
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android